Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | FEN1 | P39748 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 6/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 5/20 | 0.36 |
| ▸ | PDE4C | Q08493 | 5/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23626718 | 0.98 | KDM4E (0.45) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL23626859 | 0.96 | ALDH1A1 (0.44) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL26082048 | 0.96 | ALDH1A1 (0.44) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL21481365 | 0.96 | KDM4E (0.44) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL17348897 | 0.93 | KDM4E (0.47) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL17348710 | 0.93 | KDM4E (0.47) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL17348640 | 0.92 | ALDH1A1 (0.47) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL17348892 | 0.92 | ALDH1A1 (0.47) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL17676387 | 0.91 | KDM4E (0.49) | KDM4EATML3MBTL1ALDH1A1TSHR | |
| SCHEMBL17676394 | 0.91 | KDM4E (0.49) | KDM4EATML3MBTL1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873311-B2 | Heterocyclic compound, organic electroluminescent device, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-01-16 | — | — | US | disclosed |
| US-11873311-B2 | Heterocyclic compound, organic electroluminescent device, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-01-16 | — | — | US | disclosed |
| US-20230312604-A1 | HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-05 | — | — | US | disclosed |
| US-20230312604-A1 | HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-05 | — | — | US | disclosed |
| WO-2021136277-A1 | HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 | 2021-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312604-A1 | HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE | ODC1, LEF1, PIEZO1 | KDM4E 2765/4885ATM 3707/4885L3MBTL1 2892/4885 |
| US-11873311-B2 | Heterocyclic compound, organic electroluminescent device, and electronic device | ODC1, LEF1, PIEZO1 | KDM4E 2765/4885ATM 3707/4885L3MBTL1 2892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.